Cargando…

The Relationship between Body Composition, Fatty Acid Metabolism and Diet in Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is an autosomal recessive condition that results in pathological deficiency of the survival motor neuron (SMN) protein. SMA most frequently presents itself within the first few months of life and is characterized by progressive muscle weakness. As a neuromuscular condit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watson, Katherine S., Boukhloufi, Imane, Bowerman, Melissa, Parson, Simon H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909254/ https://www.ncbi.nlm.nih.gov/pubmed/33498293 http://dx.doi.org/10.3390/brainsci11020131

Ejemplares similares

Abnormal fatty acid metabolism is a core component of spinal muscular atrophy
por: Deguise, Marc‐Olivier, et al.
Publicado: (2019)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
por: Bowerman, Melissa, et al.
Publicado: (2017)

ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets
por: Coque, Emmanuelle, et al.
Publicado: (2014)

Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
por: Bowerman, Melissa, et al.
Publicado: (2012)

Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology
por: Bowerman, Melissa, et al.
Publicado: (2014)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

A call to introduce newborn screening for spinal muscular atrophy (SMA) in Scotland
por: Gillingwater, Thomas H., et al.
Publicado: (2022)

Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy
por: Guber, Robert D., et al.
Publicado: (2017)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy
por: Powis, Rachael A., et al.
Publicado: (2016)

Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice
por: Meijboom, Katharina E., et al.
Publicado: (2022)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA)
por: Šoltić, Darija, et al.
Publicado: (2018)

Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment
por: Sintusek, Palittiya, et al.
Publicado: (2016)

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
por: Winkelsas, Audrey M., et al.
Publicado: (2021)

Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy
por: Meijboom, Katharina E., et al.
Publicado: (2021)

Spinal Muscular Atrophy, types I and II: What are the differences in body composition and resting energy expenditure?
por: Bertoli, Simona, et al.
Publicado: (2017)

Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice
por: Walter, Lisa M, et al.
Publicado: (2018)

Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance
por: Keinath, Melissa C, et al.
Publicado: (2021)

Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy
por: Inagaki, Tomonori, et al.
Publicado: (2022)

Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy
por: Li, Yang-Jean, et al.
Publicado: (2020)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy
por: Lusakowska, Anna, et al.
Publicado: (2021)

Morphological Characteristics of Motor Neurons Do Not Determine Their Relative Susceptibility to Degeneration in a Mouse Model of Severe Spinal Muscular Atrophy
por: Thomson, Sophie R., et al.
Publicado: (2012)

Low fat diets increase survival of a mouse model of spinal muscular atrophy
por: Deguise, Marc‐Olivier, et al.
Publicado: (2019)

A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN
por: Rademacher, Sebastian, et al.
Publicado: (2020)

Microvasculopathy in spinal muscular atrophy is driven by a reversible autonomous endothelial cell defect
por: Zhou, Haiyan, et al.
Publicado: (2022)

Mitochondrial abnormalities in spinal and bulbar muscular atrophy
por: Ranganathan, Srikanth, et al.
Publicado: (2009)

Rapid molecular diagnosis of spinal muscular atrophy
por: Mittal, Balraj
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6bve33uifosdhg47qkbd799in9